CVS Caremark Corporation (NYSE:CVS)’s 10-year Agreement Boosted Stock Price Life High

Posted by George Brook December 11, 2013 0 Comment 879 views


CVS Caremark Corporation (NYSE:CVS) is a Woonsocket, Rhode Island based integrated pharmacy health care service provider that operates in Pharmacy Services segment and Retail Pharmacy segment through more than 7,450 retail drugstores and 700 specialty locations. Yesterday the company announced a 10 year agreement with Cardinal Health Inc. (NYSE:CAH) towards forming the largest generic drug sourcing operation in the U.S. through a 50-50 joint venture.

The Generic Drug Market

IMS Health which tracks prescription drug data recently revealed that generic drugs now account for more than 80% of all prescription drugs. This major shift toward cheaper generic drugs is largely evident as many patents for major brand-name treatments are expiring in recent time. Moreover such shift in the world’s biggest generic drug market would also help its recent efforts to lower costs throughout the healthcare system.

The Agreement

The 50-50 joint venture between CVS Caremark Corporation (NYSE:CVS) and Cardinal Health Inc. (NYSE:CAH) is expected to be operational latest by July 2014. This agreement would aid the generic drug purchasing power of both of these companies. As per the terms of the agreement, Cardinal Health will be paying $25 million to CVS Caremark Corporation (NYSE:CVS) on a quarterly basis, for the life of the contract.

The analysts expect this joint venture to keep check on generic drug makers from substantially increasing prices. Ross Muken, an analyst with ISI Group also anticipated in a research note that the deal would annually add earnings of $0.18-$0.20 per share to  CVS Caremark Corporation (NYSE:CVS) and approximately $0.25-$0.30 to Cardinal Health Inc. (NYSE:CAH).

The Impact

Following the announcement the stock of both these companies surged to mark fresh 52 week highs. CVS Caremark Corporation (NYSE:CVS)’s stock soared to $68.60 during yesterday’s session before closing at $67.99 and that of Cardinal Health Inc. (NYSE:CAH) surged to $67.75 before closing at $66.22.



About George Brook

George Brook covers money and politics for GDP Insider. George is a veteran journalist who has also covered Congress, national political conventions and presidential politics. George also covers the White House as well as economic and domestic policy for GDP insider. George's reporting has won numerous awards, including two Scripps Howard awards, two National Headliners, two Gerald Loeb Awards, as well as honors from Sigma Delta Chi and the National Press Club.

View all post by George Brook Visit author's website

Write Your Comment